{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "9b13f6a0",
   "metadata": {},
   "outputs": [],
   "source": [
    "import nltk\n",
    "import re\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import warnings\n",
    "import seaborn as sns\n",
    "warnings.filterwarnings('ignore', category=DeprecationWarning)\n",
    "pd.set_option('display.max_columns',None)\n",
    "pd.set_option('display.max_rows',None)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b0e5706d",
   "metadata": {},
   "outputs": [],
   "source": [
    "tweets = pd.read_json(\"C:/Users/HP/anaconda3/DataScience/NaturalLanguageProcessing/tweets.json\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "904ed1ed",
   "metadata": {},
   "outputs": [],
   "source": [
    "df= tweets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "13dd2671",
   "metadata": {},
   "outputs": [],
   "source": [
    "df=df.T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "944ec06d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>⚕️ Scientists conducted a Phase II study of ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      tweet_text  \n",
       "2013-07-18 09:39:46.071961602  ⚕️ Scientists conducted a Phase II study of ac...  \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...  \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...  \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...  \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "38e8bbb7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "41776\n"
     ]
    }
   ],
   "source": [
    "from nltk.tokenize import sent_tokenize,word_tokenize\n",
    "from nltk.corpus import stopwords\n",
    "unique_text = df.tweet_text.unique()\n",
    "print(len(unique_text))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "2ae7cf65",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>⚕️ Scientists conducted a Phase II study of ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      tweet_text  \n",
       "2013-07-18 09:39:46.071961602  ⚕️ Scientists conducted a Phase II study of ac...  \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...  \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...  \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...  \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "97c97187",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'⚕️ Scientists conducted a Phase II study of acalabrutinib in patients with relapsed/refractory #CLL who were ibrutinib-intolerant, and found an overall response rate of 73%. \\nhttps://t.co/eJ6m4QpC5P https://t.co/kuZz6ZO47r'"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['tweet_text'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "08ddd57c",
   "metadata": {},
   "outputs": [],
   "source": [
    "def remove_pattern(input_text,pattern):\n",
    "    r= re.findall(pattern,input_text)\n",
    "    for i in r:\n",
    "        input_text= re.sub(i,'',input_text)\n",
    "        \n",
    "    return input_text"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "79f29794",
   "metadata": {},
   "source": [
    "### Remove any @mentions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "10192e1e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602    ⚕️ Scientists conducted a Phase II study of ac...\n",
       "2013-07-17 03:40:32.173842437    This phase 2 Acalabrutinib-Venetoclax (AV) tri...\n",
       "2013-07-15 15:41:16.553048065    #NICE backs #AstraZenecas #Calquence for #CLL ...\n",
       "2013-07-12 19:19:42.367813635    #acalabrutinib is a valuable option in pts int...\n",
       "2013-07-04 12:40:34.334232586    NICE has recommended the use of acalabrutinib ...\n",
       "Name: clean_text, dtype: object"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['clean_text']= np.vectorize(remove_pattern)(df['tweet_text'],\"@[\\w]*\")\n",
    "df['clean_text'][0:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "b9d572c6",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "<ipython-input-11-acd3bf826c60>:1: FutureWarning: The default value of regex will change from True to False in a future version.\n",
      "  df['clean_text']= df['clean_text'].str.replace(\"[^a-zA-Z#]\",\" \")\n",
      "<ipython-input-11-acd3bf826c60>:2: FutureWarning: The default value of regex will change from True to False in a future version.\n",
      "  df['clean_text']= df['clean_text'].str.replace(\"[[\\w]'']\",\" \")\n",
      "C:\\Users\\HP\\anaconda3\\lib\\site-packages\\pandas\\core\\strings\\object_array.py:160: FutureWarning: Possible nested set at position 1\n",
      "  compiled = re.compile(pat, flags=flags)\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602       Scientists conducted a Phase II study of ac...\n",
       "2013-07-17 03:40:32.173842437    This phase   Acalabrutinib Venetoclax  AV  tri...\n",
       "2013-07-15 15:41:16.553048065    #NICE backs #AstraZenecas #Calquence for #CLL ...\n",
       "2013-07-12 19:19:42.367813635    #acalabrutinib is a valuable option in pts int...\n",
       "2013-07-04 12:40:34.334232586    NICE has recommended the use of acalabrutinib ...\n",
       "Name: clean_text, dtype: object"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['clean_text']= df['clean_text'].str.replace(\"[^a-zA-Z#]\",\" \")\n",
    "df['clean_text']= df['clean_text'].str.replace(\"[[\\w]'']\",\" \")\n",
    "df['clean_text'][0:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "744ec811",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602       scientists conducted a phase ii study of ac...\n",
       "2013-07-17 03:40:32.173842437    this phase   acalabrutinib venetoclax  av  tri...\n",
       "2013-07-15 15:41:16.553048065    #nice backs #astrazenecas #calquence for #cll ...\n",
       "2013-07-12 19:19:42.367813635    #acalabrutinib is a valuable option in pts int...\n",
       "2013-07-04 12:40:34.334232586    nice has recommended the use of acalabrutinib ...\n",
       "Name: clean_text, dtype: object"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['clean_text']= df['clean_text'].str.lower()\n",
    "df['clean_text'][0:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "52e4c7d9",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "<ipython-input-13-b2796cc204be>:1: FutureWarning: The default value of regex will change from True to False in a future version.\n",
      "  df['clean_text']=df['clean_text'].str.replace(\"[#]\",\"\")\n",
      "<ipython-input-13-b2796cc204be>:3: FutureWarning: The default value of regex will change from True to False in a future version.\n",
      "  df['clean_text']=df['clean_text'].str.replace(r'http\\S+', '')\n",
      "<ipython-input-13-b2796cc204be>:4: FutureWarning: The default value of regex will change from True to False in a future version.\n",
      "  df['clean_text']=df['clean_text'].str.replace(r'co\\S+', '')\n",
      "<ipython-input-13-b2796cc204be>:5: FutureWarning: The default value of regex will change from True to False in a future version.\n",
      "  df['clean_text']=df['clean_text'].str.replace(r'cll\\S+', '')\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602       scientists  a phase ii study of acalabrutin...\n",
       "2013-07-17 03:40:32.173842437    this phase   acalabrutinib venetoclax  av  tri...\n",
       "2013-07-15 15:41:16.553048065    nice backs astrazenecas calquence for cll    t...\n",
       "2013-07-12 19:19:42.367813635    acalabrutinib is a valuable option in pts into...\n",
       "2013-07-04 12:40:34.334232586    nice has re the use of acalabrutinib for patie...\n",
       "Name: clean_text, dtype: object"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "df['clean_text']=df['clean_text'].str.replace(\"[#]\",\"\")\n",
    "df['clean_text']=df['clean_text'].str.replace(\"'\",\"\")\n",
    "df['clean_text']=df['clean_text'].str.replace(r'http\\S+', '')\n",
    "df['clean_text']=df['clean_text'].str.replace(r'co\\S+', '')\n",
    "df['clean_text']=df['clean_text'].str.replace(r'cll\\S+', '')\n",
    "df['clean_text'][0:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "0303d367",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "      <th>clean_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>⚕️ Scientists conducted a Phase II study of ac...</td>\n",
       "      <td>scientists a phase ii study of acalabrutinib i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "      <td>this phase acalabrutinib venetoclax av trial t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "      <td>nice backs astrazenecas calquence for cll t co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "      <td>acalabrutinib is a valuable option in pts into...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "      <td>nice has re the use of acalabrutinib for patie...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      tweet_text  \\\n",
       "2013-07-18 09:39:46.071961602  ⚕️ Scientists conducted a Phase II study of ac...   \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...   \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...   \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...   \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...   \n",
       "\n",
       "                                                                      clean_text  \n",
       "2013-07-18 09:39:46.071961602  scientists a phase ii study of acalabrutinib i...  \n",
       "2013-07-17 03:40:32.173842437  this phase acalabrutinib venetoclax av trial t...  \n",
       "2013-07-15 15:41:16.553048065  nice backs astrazenecas calquence for cll t co...  \n",
       "2013-07-12 19:19:42.367813635  acalabrutinib is a valuable option in pts into...  \n",
       "2013-07-04 12:40:34.334232586  nice has re the use of acalabrutinib for patie...  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['clean_text']=df['clean_text'].apply(lambda x: ' '.join([w for w in x.split() if len(x)>2]))\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "1d88f6d0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2013-07-18 09:39:46.071961602    [scientists, a, phase, ii, study, of, acalabru...\n",
       "2013-07-17 03:40:32.173842437    [this, phase, acalabrutinib, venetoclax, av, t...\n",
       "2013-07-15 15:41:16.553048065    [nice, backs, astrazenecas, calquence, for, cl...\n",
       "2013-07-12 19:19:42.367813635    [acalabrutinib, is, a, valuable, option, in, p...\n",
       "2013-07-04 12:40:34.334232586    [nice, has, re, the, use, of, acalabrutinib, f...\n",
       "Name: clean_text, dtype: object"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tokenized_tweet = df['clean_text'].apply(lambda x: x.split())\n",
    "tokenized_tweet.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "4a4cd90e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['tokenized']=tokenized_tweet"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "e5bf29aa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "      <th>clean_text</th>\n",
       "      <th>tokenized</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>⚕️ Scientists conducted a Phase II study of ac...</td>\n",
       "      <td>scientists a phase ii study of acalabrutinib i...</td>\n",
       "      <td>[scientists, a, phase, ii, study, of, acalabru...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "      <td>this phase acalabrutinib venetoclax av trial t...</td>\n",
       "      <td>[this, phase, acalabrutinib, venetoclax, av, t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "      <td>nice backs astrazenecas calquence for cll t co...</td>\n",
       "      <td>[nice, backs, astrazenecas, calquence, for, cl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "      <td>acalabrutinib is a valuable option in pts into...</td>\n",
       "      <td>[acalabrutinib, is, a, valuable, option, in, p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "      <td>nice has re the use of acalabrutinib for patie...</td>\n",
       "      <td>[nice, has, re, the, use, of, acalabrutinib, f...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      tweet_text  \\\n",
       "2013-07-18 09:39:46.071961602  ⚕️ Scientists conducted a Phase II study of ac...   \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...   \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...   \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...   \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...   \n",
       "\n",
       "                                                                      clean_text  \\\n",
       "2013-07-18 09:39:46.071961602  scientists a phase ii study of acalabrutinib i...   \n",
       "2013-07-17 03:40:32.173842437  this phase acalabrutinib venetoclax av trial t...   \n",
       "2013-07-15 15:41:16.553048065  nice backs astrazenecas calquence for cll t co...   \n",
       "2013-07-12 19:19:42.367813635  acalabrutinib is a valuable option in pts into...   \n",
       "2013-07-04 12:40:34.334232586  nice has re the use of acalabrutinib for patie...   \n",
       "\n",
       "                                                                       tokenized  \n",
       "2013-07-18 09:39:46.071961602  [scientists, a, phase, ii, study, of, acalabru...  \n",
       "2013-07-17 03:40:32.173842437  [this, phase, acalabrutinib, venetoclax, av, t...  \n",
       "2013-07-15 15:41:16.553048065  [nice, backs, astrazenecas, calquence, for, cl...  \n",
       "2013-07-12 19:19:42.367813635  [acalabrutinib, is, a, valuable, option, in, p...  \n",
       "2013-07-04 12:40:34.334232586  [nice, has, re, the, use, of, acalabrutinib, f...  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "fac32f86",
   "metadata": {},
   "outputs": [],
   "source": [
    "stopwords = nltk.corpus.stopwords.words('english')\n",
    "df['tokenized']=df['tokenized'].apply(lambda x: [item for item in x if item not in stopwords])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "27b9e56c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "      <th>clean_text</th>\n",
       "      <th>tokenized</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>⚕️ Scientists conducted a Phase II study of ac...</td>\n",
       "      <td>scientists a phase ii study of acalabrutinib i...</td>\n",
       "      <td>[scientists, phase, ii, study, acalabrutinib, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "      <td>this phase acalabrutinib venetoclax av trial t...</td>\n",
       "      <td>[phase, acalabrutinib, venetoclax, av, trial, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "      <td>nice backs astrazenecas calquence for cll t co...</td>\n",
       "      <td>[nice, backs, astrazenecas, calquence, cll, co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "      <td>acalabrutinib is a valuable option in pts into...</td>\n",
       "      <td>[acalabrutinib, valuable, option, pts, intoler...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "      <td>nice has re the use of acalabrutinib for patie...</td>\n",
       "      <td>[nice, use, acalabrutinib, patients, treatment...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      tweet_text  \\\n",
       "2013-07-18 09:39:46.071961602  ⚕️ Scientists conducted a Phase II study of ac...   \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...   \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...   \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...   \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...   \n",
       "\n",
       "                                                                      clean_text  \\\n",
       "2013-07-18 09:39:46.071961602  scientists a phase ii study of acalabrutinib i...   \n",
       "2013-07-17 03:40:32.173842437  this phase acalabrutinib venetoclax av trial t...   \n",
       "2013-07-15 15:41:16.553048065  nice backs astrazenecas calquence for cll t co...   \n",
       "2013-07-12 19:19:42.367813635  acalabrutinib is a valuable option in pts into...   \n",
       "2013-07-04 12:40:34.334232586  nice has re the use of acalabrutinib for patie...   \n",
       "\n",
       "                                                                       tokenized  \n",
       "2013-07-18 09:39:46.071961602  [scientists, phase, ii, study, acalabrutinib, ...  \n",
       "2013-07-17 03:40:32.173842437  [phase, acalabrutinib, venetoclax, av, trial, ...  \n",
       "2013-07-15 15:41:16.553048065  [nice, backs, astrazenecas, calquence, cll, co...  \n",
       "2013-07-12 19:19:42.367813635  [acalabrutinib, valuable, option, pts, intoler...  \n",
       "2013-07-04 12:40:34.334232586  [nice, use, acalabrutinib, patients, treatment...  "
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "50db1ed7",
   "metadata": {},
   "outputs": [],
   "source": [
    "from nltk.stem import WordNetLemmatizer\n",
    "lemmatizer= WordNetLemmatizer()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "380cafb1",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "df['lemmatize'] = df['tokenized'].apply(lambda lst:[lemmatizer.lemmatize(word) for word in lst])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "75778a9c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "      <th>clean_text</th>\n",
       "      <th>tokenized</th>\n",
       "      <th>lemmatize</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>⚕️ Scientists conducted a Phase II study of ac...</td>\n",
       "      <td>scientists a phase ii study of acalabrutinib i...</td>\n",
       "      <td>[scientists, phase, ii, study, acalabrutinib, ...</td>\n",
       "      <td>[scientist, phase, ii, study, acalabrutinib, p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "      <td>this phase acalabrutinib venetoclax av trial t...</td>\n",
       "      <td>[phase, acalabrutinib, venetoclax, av, trial, ...</td>\n",
       "      <td>[phase, acalabrutinib, venetoclax, av, trial, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "      <td>nice backs astrazenecas calquence for cll t co...</td>\n",
       "      <td>[nice, backs, astrazenecas, calquence, cll, co...</td>\n",
       "      <td>[nice, back, astrazenecas, calquence, cll, co,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "      <td>acalabrutinib is a valuable option in pts into...</td>\n",
       "      <td>[acalabrutinib, valuable, option, pts, intoler...</td>\n",
       "      <td>[acalabrutinib, valuable, option, pt, intolera...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "      <td>nice has re the use of acalabrutinib for patie...</td>\n",
       "      <td>[nice, use, acalabrutinib, patients, treatment...</td>\n",
       "      <td>[nice, use, acalabrutinib, patient, treatment,...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      tweet_text  \\\n",
       "2013-07-18 09:39:46.071961602  ⚕️ Scientists conducted a Phase II study of ac...   \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...   \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...   \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...   \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...   \n",
       "\n",
       "                                                                      clean_text  \\\n",
       "2013-07-18 09:39:46.071961602  scientists a phase ii study of acalabrutinib i...   \n",
       "2013-07-17 03:40:32.173842437  this phase acalabrutinib venetoclax av trial t...   \n",
       "2013-07-15 15:41:16.553048065  nice backs astrazenecas calquence for cll t co...   \n",
       "2013-07-12 19:19:42.367813635  acalabrutinib is a valuable option in pts into...   \n",
       "2013-07-04 12:40:34.334232586  nice has re the use of acalabrutinib for patie...   \n",
       "\n",
       "                                                                       tokenized  \\\n",
       "2013-07-18 09:39:46.071961602  [scientists, phase, ii, study, acalabrutinib, ...   \n",
       "2013-07-17 03:40:32.173842437  [phase, acalabrutinib, venetoclax, av, trial, ...   \n",
       "2013-07-15 15:41:16.553048065  [nice, backs, astrazenecas, calquence, cll, co...   \n",
       "2013-07-12 19:19:42.367813635  [acalabrutinib, valuable, option, pts, intoler...   \n",
       "2013-07-04 12:40:34.334232586  [nice, use, acalabrutinib, patients, treatment...   \n",
       "\n",
       "                                                                       lemmatize  \n",
       "2013-07-18 09:39:46.071961602  [scientist, phase, ii, study, acalabrutinib, p...  \n",
       "2013-07-17 03:40:32.173842437  [phase, acalabrutinib, venetoclax, av, trial, ...  \n",
       "2013-07-15 15:41:16.553048065  [nice, back, astrazenecas, calquence, cll, co,...  \n",
       "2013-07-12 19:19:42.367813635  [acalabrutinib, valuable, option, pt, intolera...  \n",
       "2013-07-04 12:40:34.334232586  [nice, use, acalabrutinib, patient, treatment,...  "
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "4b3b5864",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import matplotlib.pyplot as plt\n",
    "from wordcloud import WordCloud"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "75ddd1f4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "input_text = df['lemmatize'].values \n",
    "\n",
    "wordcloud = WordCloud().generate(str(input_text))\n",
    "\n",
    "plt.imshow(wordcloud)\n",
    "plt.axis(\"off\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "dc7cadaa",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: textblob in c:\\users\\hp\\anaconda3\\lib\\site-packages (0.17.1)\n",
      "Requirement already satisfied: nltk>=3.1 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from textblob) (3.6.1)\n",
      "Requirement already satisfied: tqdm in c:\\users\\hp\\anaconda3\\lib\\site-packages (from nltk>=3.1->textblob) (4.59.0)\n",
      "Requirement already satisfied: regex in c:\\users\\hp\\anaconda3\\lib\\site-packages (from nltk>=3.1->textblob) (2021.4.4)\n",
      "Requirement already satisfied: joblib in c:\\users\\hp\\anaconda3\\lib\\site-packages (from nltk>=3.1->textblob) (1.0.1)\n",
      "Requirement already satisfied: click in c:\\users\\hp\\anaconda3\\lib\\site-packages (from nltk>=3.1->textblob) (7.1.2)\n",
      "Requirement already satisfied: vaderSentiment in c:\\users\\hp\\anaconda3\\lib\\site-packages (3.3.2)\n",
      "Requirement already satisfied: requests in c:\\users\\hp\\anaconda3\\lib\\site-packages (from vaderSentiment) (2.25.1)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from requests->vaderSentiment) (2020.12.5)\n",
      "Requirement already satisfied: urllib3<1.27,>=1.21.1 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from requests->vaderSentiment) (1.26.4)\n",
      "Requirement already satisfied: chardet<5,>=3.0.2 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from requests->vaderSentiment) (3.0.4)\n",
      "Requirement already satisfied: idna<3,>=2.5 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from requests->vaderSentiment) (2.10)\n",
      "Requirement already satisfied: watson_developer_cloud in c:\\users\\hp\\anaconda3\\lib\\site-packages (2.10.1)\n",
      "Requirement already satisfied: python-dateutil>=2.5.3 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from watson_developer_cloud) (2.8.1)\n",
      "Requirement already satisfied: requests<3.0,>=2.0 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from watson_developer_cloud) (2.25.1)\n",
      "Requirement already satisfied: websocket-client==0.48.0 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from watson_developer_cloud) (0.48.0)\n",
      "Requirement already satisfied: six in c:\\users\\hp\\anaconda3\\lib\\site-packages (from websocket-client==0.48.0->watson_developer_cloud) (1.15.0)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from requests<3.0,>=2.0->watson_developer_cloud) (2020.12.5)\n",
      "Requirement already satisfied: urllib3<1.27,>=1.21.1 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from requests<3.0,>=2.0->watson_developer_cloud) (1.26.4)\n",
      "Requirement already satisfied: chardet<5,>=3.0.2 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from requests<3.0,>=2.0->watson_developer_cloud) (3.0.4)\n",
      "Requirement already satisfied: idna<3,>=2.5 in c:\\users\\hp\\anaconda3\\lib\\site-packages (from requests<3.0,>=2.0->watson_developer_cloud) (2.10)\n",
      "Requirement already satisfied: config in c:\\users\\hp\\anaconda3\\lib\\site-packages (0.5.1)\n"
     ]
    }
   ],
   "source": [
    "!pip install textblob\n",
    "!pip install vaderSentiment\n",
    "!pip install watson_developer_cloud\n",
    "!pip install config"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "8866278c",
   "metadata": {},
   "outputs": [],
   "source": [
    "import glob\n",
    "from textblob import TextBlob\n",
    "from vaderSentiment.vaderSentiment import SentimentIntensityAnalyzer\n",
    "from watson_developer_cloud import NaturalLanguageUnderstandingV1\n",
    "from watson_developer_cloud.natural_language_understanding_v1 import Features,EntitiesOptions,KeywordsOptions,SentimentOptions,CategoriesOptions\n",
    "from sklearn.metrics import accuracy_score,precision_score,f1_score,confusion_matrix,classification_report\n",
    "import config"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "564e0257",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['calculated']=df['clean_text'].apply(lambda x:(TextBlob(x).sentiment.polarity))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "4912bf17",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'⚕️ Scientists conducted a Phase II study of acalabrutinib in patients with relapsed/refractory #CLL who were ibrutinib-intolerant, and found an overall response rate of 73%. \\nhttps://t.co/eJ6m4QpC5P https://t.co/kuZz6ZO47r'"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['tweet_text'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "9c81d81f",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['sentiment']=round(df['calculated'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "d032db65",
   "metadata": {},
   "outputs": [],
   "source": [
    "df3=df.drop(['tweet_text','tokenized','lemmatize'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "5ca2451d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>clean_text</th>\n",
       "      <th>calculated</th>\n",
       "      <th>sentiment</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>scientists a phase ii study of acalabrutinib i...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>this phase acalabrutinib venetoclax av trial t...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>nice backs astrazenecas calquence for cll t co...</td>\n",
       "      <td>0.60</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>acalabrutinib is a valuable option in pts into...</td>\n",
       "      <td>0.05</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>nice has re the use of acalabrutinib for patie...</td>\n",
       "      <td>0.55</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      clean_text  \\\n",
       "2013-07-18 09:39:46.071961602  scientists a phase ii study of acalabrutinib i...   \n",
       "2013-07-17 03:40:32.173842437  this phase acalabrutinib venetoclax av trial t...   \n",
       "2013-07-15 15:41:16.553048065  nice backs astrazenecas calquence for cll t co...   \n",
       "2013-07-12 19:19:42.367813635  acalabrutinib is a valuable option in pts into...   \n",
       "2013-07-04 12:40:34.334232586  nice has re the use of acalabrutinib for patie...   \n",
       "\n",
       "                               calculated  sentiment  \n",
       "2013-07-18 09:39:46.071961602        0.00        0.0  \n",
       "2013-07-17 03:40:32.173842437        0.00        0.0  \n",
       "2013-07-15 15:41:16.553048065        0.60        1.0  \n",
       "2013-07-12 19:19:42.367813635        0.05        0.0  \n",
       "2013-07-04 12:40:34.334232586        0.55        1.0  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "df3.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "1f1ab700",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>tweet_author</th>\n",
       "      <th>tweet_text</th>\n",
       "      <th>clean_text</th>\n",
       "      <th>tokenized</th>\n",
       "      <th>lemmatize</th>\n",
       "      <th>calculated</th>\n",
       "      <th>sentiment</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-07-18 09:39:46.071961602</th>\n",
       "      <td>Hematopoiesis News</td>\n",
       "      <td>⚕️ Scientists conducted a Phase II study of ac...</td>\n",
       "      <td>scientists a phase ii study of acalabrutinib i...</td>\n",
       "      <td>[scientists, phase, ii, study, acalabrutinib, ...</td>\n",
       "      <td>[scientist, phase, ii, study, acalabrutinib, p...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-17 03:40:32.173842437</th>\n",
       "      <td>Michael Wang, MD</td>\n",
       "      <td>This phase 2 Acalabrutinib-Venetoclax (AV) tri...</td>\n",
       "      <td>this phase acalabrutinib venetoclax av trial t...</td>\n",
       "      <td>[phase, acalabrutinib, venetoclax, av, trial, ...</td>\n",
       "      <td>[phase, acalabrutinib, venetoclax, av, trial, ...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-15 15:41:16.553048065</th>\n",
       "      <td>1stOncology</td>\n",
       "      <td>#NICE backs #AstraZenecas #Calquence for #CLL ...</td>\n",
       "      <td>nice backs astrazenecas calquence for cll t co...</td>\n",
       "      <td>[nice, backs, astrazenecas, calquence, cll, co...</td>\n",
       "      <td>[nice, back, astrazenecas, calquence, cll, co,...</td>\n",
       "      <td>0.60</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-12 19:19:42.367813635</th>\n",
       "      <td>Toby Eyre</td>\n",
       "      <td>#acalabrutinib is a valuable option in pts int...</td>\n",
       "      <td>acalabrutinib is a valuable option in pts into...</td>\n",
       "      <td>[acalabrutinib, valuable, option, pts, intoler...</td>\n",
       "      <td>[acalabrutinib, valuable, option, pt, intolera...</td>\n",
       "      <td>0.05</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-04 12:40:34.334232586</th>\n",
       "      <td>Lymphoma Hub</td>\n",
       "      <td>NICE has recommended the use of acalabrutinib ...</td>\n",
       "      <td>nice has re the use of acalabrutinib for patie...</td>\n",
       "      <td>[nice, use, acalabrutinib, patients, treatment...</td>\n",
       "      <td>[nice, use, acalabrutinib, patient, treatment,...</td>\n",
       "      <td>0.55</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     tweet_author  \\\n",
       "2013-07-18 09:39:46.071961602  Hematopoiesis News   \n",
       "2013-07-17 03:40:32.173842437    Michael Wang, MD   \n",
       "2013-07-15 15:41:16.553048065         1stOncology   \n",
       "2013-07-12 19:19:42.367813635           Toby Eyre   \n",
       "2013-07-04 12:40:34.334232586        Lymphoma Hub   \n",
       "\n",
       "                                                                      tweet_text  \\\n",
       "2013-07-18 09:39:46.071961602  ⚕️ Scientists conducted a Phase II study of ac...   \n",
       "2013-07-17 03:40:32.173842437  This phase 2 Acalabrutinib-Venetoclax (AV) tri...   \n",
       "2013-07-15 15:41:16.553048065  #NICE backs #AstraZenecas #Calquence for #CLL ...   \n",
       "2013-07-12 19:19:42.367813635  #acalabrutinib is a valuable option in pts int...   \n",
       "2013-07-04 12:40:34.334232586  NICE has recommended the use of acalabrutinib ...   \n",
       "\n",
       "                                                                      clean_text  \\\n",
       "2013-07-18 09:39:46.071961602  scientists a phase ii study of acalabrutinib i...   \n",
       "2013-07-17 03:40:32.173842437  this phase acalabrutinib venetoclax av trial t...   \n",
       "2013-07-15 15:41:16.553048065  nice backs astrazenecas calquence for cll t co...   \n",
       "2013-07-12 19:19:42.367813635  acalabrutinib is a valuable option in pts into...   \n",
       "2013-07-04 12:40:34.334232586  nice has re the use of acalabrutinib for patie...   \n",
       "\n",
       "                                                                       tokenized  \\\n",
       "2013-07-18 09:39:46.071961602  [scientists, phase, ii, study, acalabrutinib, ...   \n",
       "2013-07-17 03:40:32.173842437  [phase, acalabrutinib, venetoclax, av, trial, ...   \n",
       "2013-07-15 15:41:16.553048065  [nice, backs, astrazenecas, calquence, cll, co...   \n",
       "2013-07-12 19:19:42.367813635  [acalabrutinib, valuable, option, pts, intoler...   \n",
       "2013-07-04 12:40:34.334232586  [nice, use, acalabrutinib, patients, treatment...   \n",
       "\n",
       "                                                                       lemmatize  \\\n",
       "2013-07-18 09:39:46.071961602  [scientist, phase, ii, study, acalabrutinib, p...   \n",
       "2013-07-17 03:40:32.173842437  [phase, acalabrutinib, venetoclax, av, trial, ...   \n",
       "2013-07-15 15:41:16.553048065  [nice, back, astrazenecas, calquence, cll, co,...   \n",
       "2013-07-12 19:19:42.367813635  [acalabrutinib, valuable, option, pt, intolera...   \n",
       "2013-07-04 12:40:34.334232586  [nice, use, acalabrutinib, patient, treatment,...   \n",
       "\n",
       "                               calculated  sentiment  \n",
       "2013-07-18 09:39:46.071961602        0.00        0.0  \n",
       "2013-07-17 03:40:32.173842437        0.00        0.0  \n",
       "2013-07-15 15:41:16.553048065        0.60        1.0  \n",
       "2013-07-12 19:19:42.367813635        0.05        0.0  \n",
       "2013-07-04 12:40:34.334232586        0.55        1.0  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "3e44cf93",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['sentiment']=df['sentiment'].astype(int)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "32318ffd",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\HP\\anaconda3\\lib\\site-packages\\seaborn\\_decorators.py:36: FutureWarning: Pass the following variable as a keyword arg: x. From version 0.12, the only valid positional argument will be `data`, and passing other arguments without an explicit keyword will result in an error or misinterpretation.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:xlabel='sentiment', ylabel='count'>"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.countplot(df3.sentiment)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "f3f92976",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "from sklearn.model_selection import GridSearchCV\n",
    "from sklearn.ensemble import RandomForestClassifier"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "7d207d02",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.metrics import accuracy_score,precision_score,recall_score,confusion_matrix,roc_curve,classification_report\n",
    "from sklearn.metrics import plot_confusion_matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "328da102",
   "metadata": {},
   "outputs": [],
   "source": [
    "cv = CountVectorizer(ngram_range=(1,2))\n",
    "train_data = cv.fit_transform(df['tweet_text'])\n",
    "X = train_data\n",
    "y = df.sentiment"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "dba4d6ae",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.naive_bayes import MultinomialNB\n",
    "from sklearn.svm import SVC\n",
    "from sklearn.tree import DecisionTreeClassifier\n",
    "from sklearn.model_selection import train_test_split"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "73e1da58",
   "metadata": {},
   "outputs": [],
   "source": [
    "x_train,x_test,y_train,y_test=train_test_split(X,y,test_size=0.3,random_state=42)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "c700222a",
   "metadata": {},
   "outputs": [],
   "source": [
    "nb=MultinomialNB()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "ab4decf0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "MultinomialNB()"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nb.fit(x_train,y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "456ad9ef",
   "metadata": {},
   "outputs": [],
   "source": [
    "pred=nb.predict(x_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "e9149d8a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([0, 0, 0, ..., 0, 0, 0])"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pred"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "b528ade0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.9371011149557862"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "accuracy_score(y_test,pred)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "48c8e365",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[    0,    16,     0],\n",
       "       [    1, 12129,   359],\n",
       "       [    0,   442,    58]], dtype=int64)"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "confusion_matrix(y_test,pred)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "ea51e449",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "              precision    recall  f1-score   support\n",
      "\n",
      "          -1       0.00      0.00      0.00        16\n",
      "           0       0.96      0.97      0.97     12489\n",
      "           1       0.14      0.12      0.13       500\n",
      "\n",
      "    accuracy                           0.94     13005\n",
      "   macro avg       0.37      0.36      0.36     13005\n",
      "weighted avg       0.93      0.94      0.93     13005\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(classification_report(y_test,pred))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "a0c646b3",
   "metadata": {},
   "outputs": [],
   "source": [
    "dt=DecisionTreeClassifier()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "9987e9cc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "DecisionTreeClassifier()"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dt.fit(x_train,y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "334c854a",
   "metadata": {},
   "outputs": [],
   "source": [
    "pre=dt.predict(x_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "2d0e6ab5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([0, 0, 0, ..., 0, 0, 0])"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pre"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "9147db00",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.9713187235678585"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "accuracy_score(y_test,pre)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "4db1732f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[    4,    12,     0],\n",
       "       [    6, 12277,   206],\n",
       "       [    0,   149,   351]], dtype=int64)"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "confusion_matrix(y_test,pre)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "46132538",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "              precision    recall  f1-score   support\n",
      "\n",
      "          -1       0.40      0.25      0.31        16\n",
      "           0       0.99      0.98      0.99     12489\n",
      "           1       0.63      0.70      0.66       500\n",
      "\n",
      "    accuracy                           0.97     13005\n",
      "   macro avg       0.67      0.65      0.65     13005\n",
      "weighted avg       0.97      0.97      0.97     13005\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(classification_report(y_test,pre))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8b4b5526",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "54980472",
   "metadata": {},
   "outputs": [],
   "source": [
    "parameters = {'max_features': ('auto','sqrt'),\n",
    "             'n_estimators': [500, 1000, 5000],\n",
    "             'max_depth': [3, 5, None],\n",
    "             'min_samples_split': [2, 5, 10],\n",
    "             'min_samples_leaf': [1, 2, 5],\n",
    "             'bootstrap': [True, False]}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "073fb7bf",
   "metadata": {},
   "outputs": [],
   "source": [
    "grid_search = GridSearchCV(RandomForestClassifier(),parameters,cv=5,return_train_score=True,n_jobs=-1)\n",
    "grid_search.fit(X,y)\n",
    "grid_search.best_params_"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
